GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) shares passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $20.68 and traded as high as $20.98. GENMAB A/S/S shares last traded at $20.92, with a volume of 1,872,721 shares.
GENMAB A/S/S Trading Up 1.8 %
The company’s fifty day moving average price is $20.67 and its 200-day moving average price is $23.13.
GENMAB A/S/S Company Profile
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Featured Articles
- Five stocks we like better than GENMAB A/S/S
- What Are Dividend Challengers?
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- What Are Dividend Achievers? An Introduction
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Health Care Stocks Explained: Why You Might Want to Invest
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
